Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-000948
Filing Date
2025-02-13
Accepted
2025-02-13 16:30:39
Documents
80
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K glyc-20241231x10k.htm   iXBRL 10-K 2206940
2 EX-4.2 glyc-20241231xex4d2.htm EX-4.2 21422
3 EX-19.1 glyc-20241231xex19d1.htm EX-19.1 49538
4 EX-23.1 glyc-20241231xex23d1.htm EX-23.1 11683
5 EX-31.1 glyc-20241231xex31d1.htm EX-31.1 11402
6 EX-31.2 glyc-20241231xex31d2.htm EX-31.2 11713
7 EX-32.1 glyc-20241231xex32d1.htm EX-32.1 9216
  Complete submission text file 0001558370-25-000948.txt   7257730

Data Files

Seq Description Document Type Size
8 EX-101.SCH glyc-20241231.xsd EX-101.SCH 46080
9 EX-101.CAL glyc-20241231_cal.xml EX-101.CAL 50301
10 EX-101.DEF glyc-20241231_def.xml EX-101.DEF 182455
11 EX-101.LAB glyc-20241231_lab.xml EX-101.LAB 432775
12 EX-101.PRE glyc-20241231_pre.xml EX-101.PRE 356373
83 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20241231x10k_htm.xml XML 870974
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36177 | Film No.: 25620795
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)